Picture of Bioscience Neutraceuticals logo

DEVV Bioscience Neutraceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro Cap

Annual balance sheet for Bioscience Neutraceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.00200.001
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.00200.0050.0060
Total Assets0.00200.0050.0060
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.0050.0170.1340.1870.24
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities0.0050.0170.1340.1910.244
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-0.003-0.017-0.13-0.185-0.244
Total Liabilities & Shareholders' Equity0.00200.0050.0060
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email